Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HSPA8 mRNA encodes the Heat shock cognate 71 kDa protein (Hsc70), a constitutively expressed member of the Hsp70 chaperone family (UniProt P11142). Unlike inducible heat shock proteins, HSPA8 is essential for cellular homeostasis, performing critical roles in protein folding, the disassembly of clathrin-coated vesicles, and chaperone-mediated autophagy (CMA) (PubMed: 11557750, 25663481). In CMA, the HSPA8 protein recognizes specific motifs in substrate proteins and facilitates their delivery to lysosomes for degradation, a pathway often hijacked in cancer cells to support survival and proliferation (PubMed: 30104694). Consequently, HSPA8 mRNA is an emerging target for knockdown strategies using RNA interference or antisense oligonucleotides to induce proteotoxic stress in malignant cells. In the context of disease, HSPA8 mRNA is frequently upregulated in various malignancies, including breast and lung cancers, where it contributes to tumor progression and resistance to therapy (PubMed: 30104694). In autoimmune conditions like systemic lupus erythematosus (SLE), the HSPA8 protein is involved in the processing and presentation of self-antigens; the therapeutic peptide P140 (Lupuzor) targets the HSPA8 protein to modulate this process and has reached Phase III clinical trials (PubMed: 26153141). While most current clinical efforts focus on the protein product, HSPA8 mRNA remains a primary target for experimental RNA-based therapeutics aimed at depleting Hsc70 levels. However, because HSPA8 is a housekeeping gene with essential functions, therapeutic strategies must carefully manage the risk of systemic toxicity and the impairment of normal cellular proteostasis.
RNA interference and antisense-mediated degradation or translational inhibition
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heat shock cognate 71 kDa protein mRNA (HSPA8 mRNA).